Supplementary Figure S3 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Figure S3: CONSORT diagram depicting the number of included and excluded samples, and the reasons for exclusion, at each step of analysis for the PDAC cohort.</p

Supplementary Figure S2 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Figure S2: CONSORT diagram depicting the number of included and excluded samples, and the reasons for exclusion, at each step of analysis for the CRC cohort.</p

Supplementary Table S1 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Table S1: Demographic characteristics of the NSCLC, CRC, and PDAC cohorts.</p

Supplementary Table S5 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Table S5: Adjusted p-values (Benjamini-Hochberg) and coefficients for testing differential mutation status for each gene in each cluster, compared to all other clusters, in univariate logistic regressions for NSCLC, CRC, and PDAC.</p

Supplementary Table S2 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Table S2: Results for additional regression analyses.</p

Supplementary Table S6 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Table S6: Associations between clusters and covariates of interest for NSCLC, CRC, and PDAC, reported as odds ratios except for age, which is reported as the untransformed coefficient. The 95% Bonferroni confidence intervals are included in parentheses, corrected over the number of clusters for each tested covariate.</p

Supplementary Table S4 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Table S4: B-PCA loadings for NSCLC, CRC, and PDAC.</p

Supplementary Figure S1 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Figure S1: CONSORT diagram depicting the number of included and excluded samples, and the reasons for exclusion, at each step of analysis for the NSCLC cohort.</p

Supplementary Table S3 from Effects of <i>KRAS</i> Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Supplementary Table S3: Demographic characteristics of the patients included and not included in the B-PCA analyses for NSCLC, CRC, and PDAC.</p

Heteronormative citizenship and the politics of passing

Copyright © 2002 SAGE PublicationsThis article argues that, despite more ostensibly ‘out’ politicians and better anti-discrimination measures, strange forms of ‘passing’ are still taking place in public life. Heterosexual constructions of citzenship are still being privileged. The analysis uses British, Australian and US examples to draw out the implications of these forms of ‘passing’ for issues of citizen identity, policy and public behaviour. The article concludes by suggesting that existing queer theory has not engaged adequately with key issues influencing the construction of heteronormative citizenship.Carol Johnso